BIIB
Biogen (BIIB)
$
68About Biogen (BIIB)
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.
Details
Daily high
$186.80
Daily low
$183.82
Price at open
$186.68
52 Week High
$269.43
52 Week Low
$183.56
Market cap
27.0B
Dividend yield
0.00%
Volume
1.1M
Avg. volume
1.3M
P/E ratio
23.39
Biogen News
Details
Daily high
$186.80
Daily low
$183.82
Price at open
$186.68
52 Week High
$269.43
52 Week Low
$183.56
Market cap
27.0B
Dividend yield
0.00%
Volume
1.1M
Avg. volume
1.3M
P/E ratio
23.39